21.55
Precedente Chiudi:
$21.36
Aprire:
$21.35
Volume 24 ore:
81,354
Relative Volume:
2.55
Capitalizzazione di mercato:
$940.92M
Reddito:
-
Utile/perdita netta:
$-75.28M
Rapporto P/E:
-10.80
EPS:
-1.9957
Flusso di cassa netto:
$-57.45M
1 W Prestazione:
+1.99%
1M Prestazione:
+22.03%
6M Prestazione:
+19.59%
1 anno Prestazione:
+51.02%
Oculis Holding Ag Stock (OCS) Company Profile
Nome
Oculis Holding Ag
Settore
Industria
Telefono
-
Indirizzo
-
Confronta OCS con altri titoli
Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
---|---|---|---|---|---|---|
![]()
OCS
Oculis Holding Ag
|
21.55 | 1.13B | 0 | -75.28M | -57.45M | -1.9957 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
408.61 | 105.69B | 11.39B | 3.64B | 3.50B | 13.99 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
481.07 | 61.52B | 2.46B | -319.09M | -52.09M | -2.4669 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
569.17 | 60.69B | 14.21B | 4.46B | 3.56B | 39.69 |
![]()
ARGX
Argen X Se Adr
|
837.28 | 50.05B | 3.06B | 1.28B | 447.35M | 19.67 |
![]()
ONC
Beone Medicines Ltd Adr
|
318.02 | 35.25B | 4.56B | -176.77M | 225.30M | -1.7177 |
Oculis Holding Ag Stock (OCS) Upgrades & Downgrades
Data | Azione | Analista | Modifica della valutazione |
---|---|---|---|
2025-08-27 | Iniziato | Needham | Buy |
2023-12-05 | Iniziato | Chardan Capital Markets | Buy |
2023-10-05 | Iniziato | Stifel | Buy |
2023-06-14 | Iniziato | BofA Securities | Buy |
2023-06-12 | Iniziato | H.C. Wainwright | Buy |
2023-06-08 | Iniziato | Robert W. Baird | Outperform |
2023-05-10 | Iniziato | Pareto | Buy |
2023-04-28 | Iniziato | Wedbush | Outperform |
Mostra tutto
Oculis Holding Ag Borsa (OCS) Ultime notizie
How Oculis Holding AG stock compares to industry benchmarksCEO Change & Growth Oriented Trading Recommendations - newser.com
What candlestick patterns are forming on Oculis Holding AGTrade Entry Summary & Advanced Swing Trade Entry Plans - newser.com
Why Oculis Holding AG Equity Warrant stock remains undervaluedEarnings Growth Report & Pattern Based Trade Signal System - newser.com
Risk adjusted return profile for Oculis Holding AG analyzedInflation Watch & Long Hold Capital Preservation Plans - newser.com
Oculis Holding (OCS) Advances Privosegtor to Registrational Trials After FDA Meeting Will Innovation Leadership Strengthen? - simplywall.st
Can volume confirm reversal in Oculis Holding AG2025 Bull vs Bear & Comprehensive Market Scan Reports - newser.com
Why Oculis Holding AG Equity Warrant stock could outperform in 2025Weekly Stock Recap & Target Return Focused Picks - newser.com
Leading vs lagging indicators on Oculis Holding AG performanceMarket Trend Report & Trade Opportunity Analysis - newser.com
Published on: 2025-10-15 11:11:21 - newser.com
Is Oculis Holding AG Equity Warrant stock entering bullish territory2025 Dividend Review & Long-Term Growth Portfolio Plans - newser.com
What recovery options are there for Oculis Holding AGEarnings Risk Summary & Advanced Technical Analysis Signals - newser.com
Using data tools to time your Oculis Holding AG Equity Warrant exit2025 Retail Activity & Real-Time Volume Analysis - newser.com
Leading vs lagging indicators on Oculis Holding AG Equity Warrant performanceMarket Growth Summary & Free Low Drawdown Momentum Trade Ideas - newser.com
What momentum indicators show for Oculis Holding AG stockPortfolio Value Report & Low Drawdown Momentum Ideas - newser.com
Will Oculis Holding AG stock gain from strong economyWeekly Trend Report & AI Enhanced Trading Alerts - newser.com
What machine learning models say about Oculis Holding AGLong Setup & Daily Volume Surge Trade Alerts - newser.com
Oculis Publishes Notifications of Transactions by Persons Discharging Managerial Responsibilities - GlobeNewswire
Oculis Holding AG Highlights Innovative Late-Stage Pipeline at Eyecelerator and AAO Annual Meeting - Quiver Quantitative
Privosegtor advancing to registrational trials — Oculis spotlights late-stage pipeline at AAO 2025 - Stock Titan
Will Oculis Holding AG stock recover after recent dropMarket Movers & High Accuracy Buy Signal Tips - newser.com
Is Oculis Holding AG stock ready for a breakoutDay Trade & Daily Profit Focused Screening - newser.com
What’s the recovery path for long term holders of Oculis Holding AGJuly 2025 Opening Moves & Weekly High Return Stock Forecasts - newser.com
Oculis Holding AG Equity Warrant’s volatility index tracking explained2025 Support & Resistance & High Conviction Buy Zone Picks - newser.com
Live market analysis of Oculis Holding AG Equity WarrantJuly 2025 Sector Moves & AI Enhanced Trading Alerts - newser.com
Chardan Capital Issues Positive Estimate for Oculis Earnings - MarketBeat
Using RSI to spot recovery in Oculis Holding AG Equity Warrant2025 Trading Recap & Low Risk High Reward Ideas - newser.com
Will Oculis Holding AG Equity Warrant price bounce be sustainableJuly 2025 Spike Watch & Weekly Market Pulse Alerts - newser.com
Sentiment analysis tools applied to Oculis Holding AGMarket Growth Report & Stepwise Entry/Exit Trade Alerts - newser.com
Oculis Holding (NasdaqGM:OCS): Evaluating Valuation Following PIONEER Clinical Program Launch and FDA Meeting - Sahm
Why Oculis Holding AG (CR5) stock is favored by hedge fundsIPO Watch & Long-Term Capital Growth Strategies - newser.com
Chart based analysis of Oculis Holding AG trendsJuly 2025 Catalysts & Verified Momentum Stock Ideas - newser.com
Oculis Holding AG (OCS) Soars 6.3%: Is Further Upside Left in the Stock? - Yahoo Finance
Oculis' (OCS) Sell (D-) Rating Reaffirmed at Weiss Ratings - MarketBeat
Price action breakdown for Oculis Holding AG Equity WarrantEarnings Recap Summary & Consistent Return Investment Signals - newser.com
Will Oculis Holding AG (CR5) stock benefit from sector leadershipIPO Watch & Accurate Technical Buy Alerts - newser.com
Oculis Holding Ag Azioni (OCS) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):